At Quotient Sciences, I am responsible for the portfolio of 14C clinical studies that Quotient offer to address questions around drug metabolism and pharmacokinetics for pharmaceutical companies around the world. With over 30 years’ experience in study delivery, Quotient is a world leading provider of human ADME, microADME, intravenous microtracer and other radiolabelled studies to the pharmaceutical industry.